期刊文献+

沉默Chk1基因对姜黄素诱导胃癌细胞SGC7901凋亡敏感度的影响 被引量:1

Effect of Chk1 Gene Silencing on Curcumin-induced Apoptosis Susceptibility of Human Gastric Cancer SGC7901 Cells
暂未订购
导出
摘要 目的探讨siRNA沉默Chk1基因表达对姜黄素诱导胃癌细胞SGC7901凋亡和细胞周期的影响,评价其作为姜黄素治疗胃癌增敏靶点的有效性。方法采用RNAi技术在胃癌细胞SG-7901中将Chk1基因沉默,采用Western blot检测转染前后Chk1蛋白表达的变化,采用流式细胞术检测Chk1基因沉默对姜黄素诱导胃癌细胞凋亡及细胞周期变化的影响。结果转染Chk1siRNA后,胃癌细胞SGC7901中Chk1蛋白表达受抑制,明显低于对照组(P<0.05)。FCM检测结果显示,si-Chk1组较空白对照组G2/M期百分比有所降低(P<0.05),si-Chk1+Curcumin组G2/M期比例明显低于Empty vec-tor+Curcumin组(P<0.05)。siRNA沉默Chk1基因使姜黄素诱导的细胞凋亡率由(14.7±1.1)%上升到(28.9±1.8)%。结论 siRNA沉默Chk1基因可明显消除G2/M期阻滞,并显著增强姜黄素诱导胃癌细胞SGC-7901凋亡的敏感度,提示Chk1可作为姜黄素治疗胃癌的有效增敏靶点。 Objective To investigate the effect of siRNA targeting checkpoint kinase 1 (Chikl) on curcu- rain-induced apopotosis and cell cycle of human gastric cancer SGC7901 cells, so as to evaluate the role of Chkl as a therapeutic target to sensitize human gastric cancer to curcumin. Methods The SGC7901 cells were transfected with siRNA-Chkl. The protein expression of Chkl was detected by Western blotting. Cell cycle phase distribution and cell apoptosis were determined by flow cytometry (FCM). Results Compared with the control group, the Chkl protein expression was significantly reduced in siRNA-Chkl transfection group (P〈0. 05). Further investigation revealed that the percentage of the G2/M phase cells of si-Chkl group was lower of than that of the control group (P〈0. 05) and the percentage of the G2/M phase cells was lower of than that of Empty vector + Curcumin group (P〈0. 05). Transfection of si-Chkl led to increased apoptotic rate from (14. 7± 1.1)% to (28. 9 ± 1.8)%. Conclusion Transfection of si- Chkl decreased G2/M arrest and sensitized SGC7901 cells to curcumin-induced apoptosis, suggesting that Chkl could be a potential therapeutic target to sensitize human gastric cancer to curcumin.
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2013年第8期748-751,共4页 Cancer Research on Prevention and Treatment
关键词 细胞周期检测点激酶1 RNA干扰 姜黄素 细胞凋亡 Checkpoint kinase 1 RNA interference Curcumin Cell apoptosis
  • 相关文献

参考文献9

  • 1Janetka JW, Ashwell S. Checkpoint kinase inhibitors., a review of the patent literature[J]. Expert Opin Ther Pat, 2009, 19 (2) :165-97.
  • 2Hatcher H, Planalp R, Cho J, et al. Cureumin: from ancient medicine to current clinical trials [J]. Cell Mol Life Sei, 2008, 65(11):1631 52.
  • 3Herman-Antosiewicz A,Stan SD, Hahm ER, et al. Activation of a novel ataxia-telangieetasia mutated and Rad3 related/ checkpoint kinase l-dependent prometaphase checkpoint in cancer cells by diallyl trisulfide, a promising dancer chemopre- ventive constituent of processed garlic[J]. Mol Cancer Ther, 2007,6(4) : 1249-61.
  • 4Ashwell S, Zabludoff S. DNA damage detection and repair pathways--recent advances with inhibitors of checkpoint kina- ses in cancer therapy [J]. Clin Cancer Res,2008,14(13) :4032- 7.
  • 5Tse AN, Carvaial R, Schwartz GK. Targeting checkpoint ki- nase 1 in cancer therapeutics[J]. Clin Cancer Res, 2007,13 (7) : 1955-60.
  • 6Wang WZ,Cheng J, Luo J, et al. Abrogation of G2/M arrest sensitizes curcumin resistant hepatoma cells to apoptosis[J]. FEBS Lett,2008,582(18) :2689-95.
  • 7Wu SH,Hang LW,YangJS,etal. Curcumin induces apoptosis in human non-small cell lung cancer NCI-H460 cells through ER stress and caspase cascade- and mitochondria-dependent pathways[J]. Anticancer Res, 2010,30 (6) : 2125-33.
  • 8Sahu RP,Batra S,Srivastava SK. Activation of ATM/Chkl by curcumin causes cell cycle arrest and apoptosis in human pan- creatic cancer cells[J]. Br J Cancer, 2009,100 ( 9 ) : 1425-33.
  • 9Parsels LA,Morgan MA,Tanska DM,etal. Gemcitabine sen- sitization by checkpoint kinase I inhibition correlates with inhi- bition of a Rad51 DNA damage response in pancreatic cancer eells[J].Mol Cancer Ther, 2009,8 ( 1 ) : 45-54.

同被引文献7

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部